0001738266-18-000001.txt : 20180424 0001738266-18-000001.hdr.sgml : 20180424 20180424151640 ACCESSION NUMBER: 0001738266-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180424 DATE AS OF CHANGE: 20180424 EFFECTIVENESS DATE: 20180424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ocuphire Pharma, Inc. CENTRAL INDEX KEY: 0001738266 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310880 FILM NUMBER: 18771276 BUSINESS ADDRESS: STREET 1: 6894 LAKEMONT CIRCLE CITY: WEST BLOOMFIELD STATE: MI ZIP: 48323 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 6894 LAKEMONT CIRCLE CITY: WEST BLOOMFIELD STATE: MI ZIP: 48323 D 1 primary_doc.xml X0708 D LIVE 0001738266 Ocuphire Pharma, Inc. 6894 LAKEMONT CIRCLE WEST BLOOMFIELD MI MICHIGAN 48323 248-681-9815 DELAWARE None None Corporation true 2018 Mina Sooch 6894 Lakemont Circle West Bloomfield MI MICHIGAN 48323 Executive Officer Director Meyer Alan 6894 Lakemont Circle West Bloomfield MI MICHIGAN 48323 Director Biotechnology Decline to Disclose 06b false 2018-04-10 false true true 0 17000 17000 0 The Company issued common stock in connection with a merger transaction. For purposes hereof only, the common stock was given a per share value of $.01 false 72 0 true 0 true 0 true false Ocuphire Pharma, Inc. Mina Sooch Mina Sooch CEO and President 2018-04-24